Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavio Forrer

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|December 6, 2006
Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotateEdgar J Rolleman, Flavio Forrer, Bert Bernard, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 13, 2010
Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumoursKeelara Abiraj, Rosalba Mansi, Maria-Luisa Tamma, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2010
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumoursRosalba Mansi, Xuejuan Wang, Flavio Forrer, et al.
Endocrine-Related Cancer|June 30, 2016
Myeloid neoplasms after chemotherapy and PRRT: myth and realityLisa Bodei, Irvin M Modlin, Markus Luster, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2009
Glucagon-like peptide-1 receptor imaging for localization of insulinomasEmanuel Christ, Damian Wild, Flavio Forrer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 15, 2011
Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumorsKeelara Abiraj, Rosalba Mansi, Maria-Luisa Tamma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclidesRosalba Mansi, Xuejuan Wang, Flavio Forrer, et al.
Medicine|April 9, 2016
Successful Medical Treatment of Adult Nesidioblastosis With Pasireotide over 3 Years: A Case ReportVerena Schwetz, Karl Horvath, Patrizia Kump, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 16, 2011
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compoundsFrancesco Giammarile, Lisa Bodei, Carlo Chiesa, et al.
Oncology|November 17, 2021
Variations in Radioiodine Therapy in Europe: Decision-Making after Total ThyroidectomyFlavio Forrer, Galina Farina Fischer, Ole Maas, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
European Journal of Nuclear Medicine and Molecular Imaging|December 6, 2006
Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotateEdgar J Rolleman, Flavio Forrer, Bert Bernard, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 13, 2010
Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumoursKeelara Abiraj, Rosalba Mansi, Maria-Luisa Tamma, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2010
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumoursRosalba Mansi, Xuejuan Wang, Flavio Forrer, et al.
Endocrine-Related Cancer|June 30, 2016
Myeloid neoplasms after chemotherapy and PRRT: myth and realityLisa Bodei, Irvin M Modlin, Markus Luster, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2009
Glucagon-like peptide-1 receptor imaging for localization of insulinomasEmanuel Christ, Damian Wild, Flavio Forrer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 15, 2011
Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumorsKeelara Abiraj, Rosalba Mansi, Maria-Luisa Tamma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclidesRosalba Mansi, Xuejuan Wang, Flavio Forrer, et al.
Medicine|April 9, 2016
Successful Medical Treatment of Adult Nesidioblastosis With Pasireotide over 3 Years: A Case ReportVerena Schwetz, Karl Horvath, Patrizia Kump, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 16, 2011
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compoundsFrancesco Giammarile, Lisa Bodei, Carlo Chiesa, et al.
Oncology|November 17, 2021
Variations in Radioiodine Therapy in Europe: Decision-Making after Total ThyroidectomyFlavio Forrer, Galina Farina Fischer, Ole Maas, et al.
Pageof 4